• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌抗原125在持续性非卧床腹膜透析期间于腹膜腔内局部产生。

Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis.

作者信息

Koomen G C, Betjes M G, Zemel D, Krediet R T, Hoek F J

机构信息

Department of Clinical Chemistry, University of Amsterdam, The Netherlands.

出版信息

Perit Dial Int. 1994;14(2):132-6.

PMID:8043665
Abstract

The local production of cancer antigen (CA) 125 in the peritoneal cavity of 14 continuous ambulatory peritoneal dialysis patients was studied. In addition, the relationship between the concentration of mesothelial cells and CA 125 in the peritoneal dialysate effluent was examined. The median results and ranges were as follows: plasma CA 125 14 U/mL (range 10-23), dialysate CA 125 18 U/mL (range 5.2-76), dialysate/plasma ratio 1.9 (range 0.61-5.4), and number of mesothelial cells 400/mL (range 10-5000). Peritoneal concentrations of mesothelial cells and CA 125 were positively correlated (r = 0.50, p < 0.01). Using a monoclonal antibody, CA 125-positive cells were found in the cytospin preparations of the cells of dialysis effluents. All these CA 125 positive cells were also positive for cytokeratin used as a mesothelial cell marker. In vitro experiments using mesothelial cells in monolayers showed a linear increase in CA 125 concentration both in time and in relation to the number of mesothelial cells. From these experiments a production rate of 24 U/hour/10(6) cells could be calculated. It is therefore concluded that CA 125 is locally produced in the peritoneal cavity during CAPD and that the mesothelial cells are the major source of this CA 125.

摘要

研究了14例持续性非卧床腹膜透析患者腹腔内癌抗原(CA)125的局部产生情况。此外,还检测了腹膜透析流出液中间皮细胞浓度与CA 125之间的关系。中位数结果及范围如下:血浆CA 125为14 U/mL(范围10 - 23),透析液CA 125为18 U/mL(范围5.2 - 76),透析液/血浆比值为1.9(范围0.61 - 5.4),间皮细胞数量为400/mL(范围10 - 5000)。腹膜中间皮细胞浓度与CA 125呈正相关(r = 0.50,p < 0.01)。使用单克隆抗体,在透析流出液细胞的细胞涂片制剂中发现了CA 125阳性细胞。所有这些CA 125阳性细胞对用作间皮细胞标志物的细胞角蛋白也呈阳性。使用单层间皮细胞的体外实验表明,CA 125浓度随时间以及与间皮细胞数量均呈线性增加。从这些实验中可以计算出产生率为24 U/小时/10(6)个细胞。因此得出结论,在持续性非卧床腹膜透析期间,CA 125在腹腔内局部产生,且间皮细胞是这种CA 125的主要来源。

相似文献

1
Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis.癌抗原125在持续性非卧床腹膜透析期间于腹膜腔内局部产生。
Perit Dial Int. 1994;14(2):132-6.
2
Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.稳定持续非卧床腹膜透析患者的透析液细胞群和癌抗原125:它们与转运参数的关系
Am J Kidney Dis. 1997 May;29(5):699-705. doi: 10.1016/s0272-6386(97)90122-0.
3
Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis.夜间间皮细胞脱落:预测持续非卧床腹膜透析患者未来超滤失败的神奇工具。
Perit Dial Int. 2008 Jun;28 Suppl 3:S107-13.
4
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.
Nephrol Dial Transplant. 1995;10(1):64-9.
5
[Evaluation of a simple area measurement method of mesothelial cells in continuous ambulatory peritoneal dialysis effluent].[持续性非卧床腹膜透析流出液中间皮细胞简单面积测量方法的评估]
Rinsho Byori. 2012 Feb;60(2):110-5.
6
Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析患者腹膜间皮细胞细胞学与腹膜组织病理学之间的相关性及其对预后的影响
Nephron. 2001 Sep;89(1):43-9. doi: 10.1159/000046042.
7
Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.持续非卧床腹膜透析患者腹腔内一氧化氮的产生
Blood Purif. 2004;22(2):216-23. doi: 10.1159/000076856.
8
Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.腹膜间皮细胞癌抗原125的表达不受腹膜透析时间的影响。
Perit Dial Int. 2001 Sep-Oct;21(5):495-500.
9
Effect of the dialysate effluent from CAPD patients on peritoneal mesothelial cells and fibroblasts.持续性非卧床腹膜透析(CAPD)患者透析液流出物对腹膜间皮细胞和成纤维细胞的影响。
Adv Perit Dial. 1994;10:230-4.
10
Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis.腹膜间皮细胞和成纤维细胞在腹膜透析期间透明质酸合成中的作用。
Perit Dial Int. 1998 Jul-Aug;18(4):382-6.

引用本文的文献

1
Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.稳定腹膜透析患者的腹膜透析流出液和血清CA125浓度
J Nephrol. 2016 Jun;29(3):427-434. doi: 10.1007/s40620-015-0250-9. Epub 2015 Nov 30.
2
The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure.腹透液Ca125与腹膜透析技术失败的相关性
Perit Dial Int. 2015 Dec;35(7):683-90. doi: 10.3747/pdi.2014.00016. Epub 2015 Jul 7.
3
Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis.
在伴有和不伴有腹膜硬化的患者中使用非葡萄糖透析液治疗严重超滤失败。
NDT Plus. 2008 Oct;1(Suppl 4):iv63-iv70. doi: 10.1093/ndtplus/sfn127.
4
The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients.腹膜透析患者细胞释放所致的流出液钾、自由水转运与CA125之间的关系。
NDT Plus. 2008 Oct;1(Suppl 4):iv41-iv45. doi: 10.1093/ndtplus/sfn123.
5
Monitoring of the peritoneal membrane.腹膜监测
NDT Plus. 2008 Oct;1(Suppl 4):iv29-iv35. doi: 10.1093/ndtplus/sfn121.
6
Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis.腹膜CA 125在急性腹膜炎腹膜透析患者中的诊断及预后作用
BMC Nephrol. 2014 Sep 12;15:149. doi: 10.1186/1471-2369-15-149.
7
Re: Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?关于:癌抗原125作为腹膜透析生物标志物:间皮细胞健康还是死亡?
Perit Dial Int. 2013 Nov-Dec;33(6):718-9. doi: 10.3747/pdi.2013.00254.
8
Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?癌抗原125作为腹膜透析中的生物标志物:间皮细胞健康还是死亡?
Perit Dial Int. 2013 Nov-Dec;33(6):715-8. doi: 10.3747/pdi.2013.00223.
9
Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.长期腹膜透析患者的透析液癌抗原125
Clin Exp Nephrol. 2014 Feb;18(1):10-5. doi: 10.1007/s10157-013-0823-7. Epub 2013 Jun 12.
10
Peritoneal changes in patients on long-term peritoneal dialysis.长期腹膜透析患者的腹膜变化。
Nat Rev Nephrol. 2013 Jul;9(7):419-29. doi: 10.1038/nrneph.2013.99. Epub 2013 May 14.